Technology News and Research

RSS

Genetics may play major role in Lou Gehrig's disease, study reveals

Genetics may play a larger role in causing Lou Gehrig's disease than previously believed, potentially accounting for more than one-third of all cases, according to one of the most comprehensive genetic studies to date of patients who suffer from the condition also known as amyotrophic lateral sclerosis, or ALS.

6 Dec 2014

IRC plans to deploy electronic medical records in fight against Ebola

The International Rescue Committee today announced that it is testing and plans to deploy electronic medical records in the fight against Ebola.

5 Dec 2014

Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

The American Gastroenterological Association Research Foundation is pleased to announce that Ashish Nimgaonkar, MBBS, MTech, MS, from John Hopkins University, has received the inaugural AGA-Boston Scientific Career Development Technology & Innovation Award. This award is graciously supported by a grant from Boston Scientific, a leading innovator of medical solutions.

5 Dec 2014

Cellular Research announces commercial availability of Precise targeted RNASeq assays

Cellular Research today announced the commercial launch of its Precise targeted RNASeq assays. The company also announced the commercial availability of application-focused panels for the Precise assays, including panels designed for oncology, induced pluripotent stem cells and immunology.

5 Dec 2014

Isis Pharmaceuticals CEO honored with SCRIP Lifetime Achievement Award

Stanley T. Crooke, Ph.D., M.D., founder, CEO and chairman of the board of directors of Isis Pharmaceuticals, Inc., has been awarded the 2014 SCRIP Lifetime Achievement Award, one of the most prestigious of its kind in the pharmaceutical and biotechnology industries worldwide.

5 Dec 2014

Two medical imaging techniques could predict effectiveness of TB drugs

Two medical imaging techniques, called positron emission tomography (PET) and computed tomography (CT), could be used in combination as a biomarker to predict the effectiveness of antibiotic drug regimens being tested to treat tuberculosis (TB) patients, according to researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

5 Dec 2014

Primary care can help tackle mental health care disparities among ethnic minorities

Primary care that includes mental health screenings and treatments that take into account a patient's language and cultural background can help address mental health care disparities among ethnic minorities, according to psychologists, physicians and other health care experts writing in a special issue of Psychological Services, published by the American Psychological Association.

5 Dec 2014

Scientists seek to improve stem cell transplant outcomes using DNA sequencing, mathematical modeling

Is the human immune system similar to the weather, a seemingly random yet dynamical system that can be modeled based on past conditions to predict future states? Scientists at VCU Massey Cancer Center's award-winning Bone Marrow Transplant (BMT) Program believe it is, and they recently published several studies that support the possibility of using next-generation DNA sequencing and mathematical modeling to not only understand the variability observed in clinical outcomes of stem cell transplantation, but also to provide a theoretical framework to make transplantation a possibility for more patients who do not have a related donor.

5 Dec 2014

UH professors receive NIH grant to combat drug-resistant bacteria

Addressing the relentless game of cat and mouse played between antibiotics and bacteria, a pair of University of Houston professors recently received a $519,000 grant from the National Institutes of Health.

5 Dec 2014

DePuy Synthes Spine receives FDA clearance to market VEPTR/VETPR II Devices for TIS treatment

DePuy Synthes Spine today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the VEPTR/VEPTR II Vertical Expandable Prosthetic Titanium Rib Devices for the treatment of Thoracic Insufficiency Syndrome (TIS), a rare congenital condition where severe deformities of the chest, spine or ribs impair breathing and lung growth in children.

5 Dec 2014

SurgiQuest receives Most Promising Life Sciences Company of the Year award

SurgiQuest was awarded "Most Promising Life Sciences Company of the Year" due to its potential for growth, success and impact on the Life Sciences market in Connecticut. The company's flagship product, the AirSeal System, improves patient outcomes, enhances perioperative efficiency, reduces costs and increases hospital profitability.

4 Dec 2014

Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation.

4 Dec 2014

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients.

4 Dec 2014

myMEDholiday.com launches digital medical tourism destinations guides

The most comprehensive online source for medical tourism information, myMEDholiday.com, has launched a series of digital guides that provide detailed information about 16 popular medical tourism destinations. The destinations in the range so far include: Thailand, Brazil, Costa Rica, Mexico, Malaysia, Panama, Greece, India, Hungary, and many more.

4 Dec 2014

Oncologists examine efficacy of rose bengal against cancer

Rose Bengal has been around for decades starting as a way to dye wool. Originally used in medicine as a stain for ophthalmologists, it has a solid safety record going back to the 1930s. Recently, oncologists have examined its efficacy against cancer, specifically melanoma.

4 Dec 2014

Peterson Center on Healthcare announces three major initiatives to improve U.S. healthcare

Today, the Peterson Center on Healthcare, a new organization established by the Peter G. Peterson Foundation, announced three major initiatives to advance the Center's mission to transform U.S. healthcare into a high-performance system that delivers high-quality care at a lower cost.

4 Dec 2014

New technology reveals cellular gene transcription process in detail

A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.

4 Dec 2014

Controlling neural excitations may help prevent detrimental effects like those in stroke, say scientists

What do lasers, neural networks, and spreading epidemics have in common? They share a most basic feature whereby an initial pulse can propagate through a medium - be it physical, biological or socio-economic, respectively. The challenge is to gain a better understanding - and eventually control - of such systems, allowing them to be applied, for instance to real neural systems. This is the objective of a new theoretical study published in EPJ B by Clemens Bachmair and Eckehard Schöll from the Berlin University of Technology in Germany.

4 Dec 2014

Leica Biosystems completes acquisition of Devicor Medical Products

Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has successfully completed its previously announced acquisition of Devicor Medical Products, Inc.

4 Dec 2014

Alizé Pharma obtains exclusive worldwide rights to develop new therapy for bone diseases

Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.

4 Dec 2014

Technology News and Research

Genetics may play major role in Lou Gehrig's disease, study reveals

IRC plans to deploy electronic medical records in fight against Ebola

Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

Cellular Research announces commercial availability of Precise targeted RNASeq assays

Isis Pharmaceuticals CEO honored with SCRIP Lifetime Achievement Award

Two medical imaging techniques could predict effectiveness of TB drugs

Primary care can help tackle mental health care disparities among ethnic minorities

Scientists seek to improve stem cell transplant outcomes using DNA sequencing, mathematical modeling

UH professors receive NIH grant to combat drug-resistant bacteria

DePuy Synthes Spine receives FDA clearance to market VEPTR/VETPR II Devices for TIS treatment

SurgiQuest receives Most Promising Life Sciences Company of the Year award

Fiagon's ENT Extended Instrument Set receives FDA approval

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

myMEDholiday.com launches digital medical tourism destinations guides

Oncologists examine efficacy of rose bengal against cancer

Peterson Center on Healthcare announces three major initiatives to improve U.S. healthcare

New technology reveals cellular gene transcription process in detail

Controlling neural excitations may help prevent detrimental effects like those in stroke, say scientists

Leica Biosystems completes acquisition of Devicor Medical Products

Alizé Pharma obtains exclusive worldwide rights to develop new therapy for bone diseases

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News